Cosmo Bio
Private Company
Total funding raised: $10.3M
Overview
Cosmo Bio USA, founded in 2004 and headquartered in Carlsbad, California, operates as a niche distributor in the life sciences sector, specializing in diagnostics and antibody-related reagents. The company differentiates itself through exclusive partnerships with over 70 Japanese manufacturers and select international innovators, providing U.S. and global researchers with difficult-to-source products. It generates revenue by selling these curated reagents and offers value-added services like personalized scientific support and import logistics assistance. As a private, revenue-generating entity, it serves as a critical bridge between specialized manufacturers and the research community.
Technology Platform
A curated distribution and scientific support ecosystem providing exclusive access to specialized life science reagents from a global network (primarily Japanese) of manufacturers, combined with expert technical guidance and logistics management.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Operates in a niche segment of the highly competitive life science distribution market, dominated by global giants like Thermo Fisher Scientific and Merck. Its differentiation lies in exclusive access to Japanese innovations and personalized scientific support, competing on specialization and expertise rather than catalog breadth or scale.